Pharm-Olam has conducted clinical trials in Spain since 2004 and we have an office in the capital city of Madrid. Our studies in Spain have supported successful US NDA and EMA approval in gram positive infections. Our Madrid office supports regional staff in Portugal.
Pharm-Olam offers comprehensive services and functional outsourcing for Phase I to IV clinical research studies in Spain, including monitoring, regulatory, pharmacovigilance (including EudraVigilance), data management, project management, and biostatistics.
For more information on conducting clinical trials with Pharm-Olam in Spain, please Contact Us.